
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $16.6M | $19.4M | $17.8M | |
Revenue Growth (YoY) | -- | -- | -- | 16.57% | -8.16% | |
Cost of Revenues | -- | -- | $14.2M | $16.7M | $14.1M | |
Gross Profit | -- | -- | $2.4M | $2.6M | $3.6M | |
Gross Profit Margin | -- | -- | 14.4% | 13.66% | 20.45% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $2.6M | $2.3M | $1.2M | |
Other Inc / (Exp) | -- | -- | $539K | -$345.6K | $2.8K | |
Operating Expenses | -- | -- | $2.6M | $2.3M | $1.2M | |
Operating Income | -- | -- | -$166.6K | $326.4K | $2.4M | |
Net Interest Expenses | -- | -- | $1.9M | $2.1M | $1.2M | |
EBT. Incl. Unusual Items | -- | -- | -$1.5M | -$2.1M | $1.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $210 | $3.8K | -- | |
Net Income to Company | -- | -- | -$1.5M | -$2.1M | $1.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$1.5M | -$2.1M | $1.2M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.13 | -$0.18 | $0.10 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.13 | -$0.18 | $0.10 | |
Weighted Average Basic Share | -- | -- | $11.9M | $11.9M | $11.9M | |
Weighted Average Diluted Share | -- | -- | $11.9M | $11.9M | $11.9M | |
EBITDA | -- | -- | -$630.1K | $6.7K | $2.5M | |
EBIT | -- | -- | -$690.2K | -$19.1K | $2.4M | |
Revenue (Reported) | -- | -- | $16.6M | $19.4M | $17.8M | |
Operating Income (Reported) | -- | -- | -$166.6K | $326.4K | $2.4M | |
Operating Income (Adjusted) | -- | -- | -$690.2K | -$19.1K | $2.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $4.2M | $3.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -37.74% | |
Cost of Revenues | -- | -- | -- | $3.9M | $3.2M | |
Gross Profit | -- | -- | -- | $346.7K | $677.8K | |
Gross Profit Margin | -- | -- | -- | 8.17% | 17.51% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $379K | $10.8M | |
Other Inc / (Exp) | -- | -- | -- | -$48.7K | $27.9K | |
Operating Expenses | -- | -- | -- | $379K | $10.8M | |
Operating Income | -- | -- | -- | -$32.3K | -$10.1M | |
Net Interest Expenses | -- | -- | -- | $231.5K | $178.9K | |
EBT. Incl. Unusual Items | -- | -- | -- | -$312.5K | -$10.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$312.5K | -$10.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$312.5K | -$10.2M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.56 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.56 | |
Weighted Average Basic Share | -- | -- | -- | $11.9M | $18.3M | |
Weighted Average Diluted Share | -- | -- | -- | $11.9M | $18.3M | |
EBITDA | -- | -- | -- | -$78.8K | -$10.1M | |
EBIT | -- | -- | -- | -$81K | -$10.1M | |
Revenue (Reported) | -- | -- | -- | $4.2M | $3.9M | |
Operating Income (Reported) | -- | -- | -- | -$32.3K | -$10.1M | |
Operating Income (Adjusted) | -- | -- | -- | -$81K | -$10.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $16.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $13.4M | |
Gross Profit | -- | -- | -- | -- | $3.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | $11.7M | |
Other Inc / (Exp) | -- | -- | -- | -$225.3K | -$8.2K | |
Operating Expenses | -- | -- | -- | -- | $11.7M | |
Operating Income | -- | -- | -- | -- | -$8.4M | |
Net Interest Expenses | -- | -- | -- | $1.2M | $906K | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -$9.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$9.3M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.48 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.48 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -$8.4M | |
EBIT | -- | -- | -- | -- | -$8.4M | |
Revenue (Reported) | -- | -- | -- | -- | $16.6M | |
Operating Income (Reported) | -- | -- | -- | -- | -$8.4M | |
Operating Income (Adjusted) | -- | -- | -- | -- | -$8.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $4.2M | $3.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $3.9M | $3.2M | |
Gross Profit | -- | -- | -- | $346.7K | $677.8K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $379K | $10.8M | |
Other Inc / (Exp) | -- | -- | -- | -$48.7K | $27.9K | |
Operating Expenses | -- | -- | -- | $379K | $10.8M | |
Operating Income | -- | -- | -- | -$32.3K | -$10.1M | |
Net Interest Expenses | -- | -- | -- | $231.5K | $178.9K | |
EBT. Incl. Unusual Items | -- | -- | -- | -$312.5K | -$10.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$312.5K | -$10.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$312.5K | -$10.2M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.56 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.03 | -$0.56 | |
Weighted Average Basic Share | -- | -- | -- | $11.9M | $18.3M | |
Weighted Average Diluted Share | -- | -- | -- | $11.9M | $18.3M | |
EBITDA | -- | -- | -- | -$78.8K | -$10.1M | |
EBIT | -- | -- | -- | -$81K | -$10.1M | |
Revenue (Reported) | -- | -- | -- | $4.2M | $3.9M | |
Operating Income (Reported) | -- | -- | -- | -$32.3K | -$10.1M | |
Operating Income (Adjusted) | -- | -- | -- | -$81K | -$10.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $96.2K | $607.9K | $38.7K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | $4.4M | $7.1M | $10.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | $15.1K | $56K | $99.5K | |
Total Current Assets | -- | -- | $4.5M | $8.4M | $10.9M | |
Property Plant And Equipment | -- | -- | $3.4M | $33.7K | $20.3K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | $6.6M | $6.6M | $6.6M | |
Other Intangibles | -- | -- | -- | $3.7M | $4.2M | |
Other Long-Term Assets | -- | -- | -- | -- | $1.8M | |
Total Assets | -- | -- | $16.5M | $20.8M | $25.6M | |
Accounts Payable | -- | -- | $1.2M | $2.1M | $3.6M | |
Accrued Expenses | -- | -- | $1.5M | $2.2M | $3.6M | |
Current Portion Of Long-Term Debt | -- | -- | $1.7M | $5.1M | $4.7M | |
Current Portion Of Capital Lease Obligations | -- | -- | $121.8K | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $9.9M | $14.1M | $18.7M | |
Long-Term Debt | -- | -- | $333.3K | $146.8K | $146.8K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $11.5M | $15.5M | $20.2M | |
Common Stock | -- | -- | $14.6K | $1K | $1.9M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | $5M | $5.2M | $5.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | $5M | $5.2M | $5.4M | |
Total Liabilities and Equity | -- | -- | $16.5M | $20.8M | $25.6M | |
Cash and Short Terms | -- | -- | $96.2K | $607.9K | $38.7K | |
Total Debt | -- | -- | $7.4M | $9.8M | $10.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $2.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $3.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | $110.9K | |
Total Current Assets | -- | -- | -- | -- | $6.7M | |
Property Plant And Equipment | -- | -- | -- | -- | $18.6K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | $20.5M | |
Other Intangibles | -- | -- | -- | -- | $4.2M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | -- | $31.5M | |
Accounts Payable | -- | -- | -- | -- | $5.7M | |
Accrued Expenses | -- | -- | -- | -- | $4.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $4.4M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | -- | -- | $21.8M | |
Long-Term Debt | -- | -- | -- | -- | $295.3K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | $22.1M | |
Common Stock | -- | -- | -- | -- | $3.2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -$3.5M | |
Total Equity | -- | -- | -- | -- | $9.4M | |
Total Liabilities and Equity | -- | -- | -- | -- | $31.5M | |
Cash and Short Terms | -- | -- | -- | -- | $2.3M | |
Total Debt | -- | -- | -- | -- | $11M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$1.5M | -$2.1M | $1.2M | |
Depreciation & Amoritzation | -- | -- | $60.1K | $25.8K | $30K | |
Stock-Based Compensation | -- | -- | $243.4K | $327.5K | $10K | |
Change in Accounts Receivable | -- | -- | -$2.5M | -$4.6M | -$3.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$2.8M | -$2M | -$1.4M | |
Capital Expenditures | -- | -- | $671.1K | $506.7K | $448K | |
Cash Acquisitions | -- | -- | -- | -- | $2.1K | |
Cash From Investing | -- | -- | -$671.2K | -$706.7K | -$885.1K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $4.5M | $1.4M | $689.3K | |
Long-Term Debt Repaid | -- | -- | -$1.5M | -$222.7K | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | $2.9M | $3.2M | $1.7M | |
Beginning Cash (CF) | -- | -- | $666.6K | $96.2K | $607.9K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$570.4K | $511.7K | -$567.1K | |
Ending Cash (CF) | -- | -- | $96.2K | $607.9K | $40.8K | |
Levered Free Cash Flow | -- | -- | -$3.5M | -$2.5M | -$1.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$312.5K | -$10.2M | |
Depreciation & Amoritzation | -- | -- | -- | $2.2K | $10K | |
Stock-Based Compensation | -- | -- | -- | $10K | $9.3M | |
Change in Accounts Receivable | -- | -- | -- | -$507.1K | -$1.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$272.5K | -$2.7M | |
Capital Expenditures | -- | -- | -- | $105K | $70K | |
Cash Acquisitions | -- | -- | -- | -- | $35K | |
Cash From Investing | -- | -- | -- | -$105K | $1.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $899.7K | |
Long-Term Debt Repaid | -- | -- | -- | -$23.5K | -$34.4K | |
Repurchase of Common Stock | -- | -- | -- | -- | -$1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -$23.5K | $3.2M | |
Beginning Cash (CF) | -- | -- | -- | $607.9K | $40.8K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$400.9K | $2.2M | |
Ending Cash (CF) | -- | -- | -- | $206.9K | $2.3M | |
Levered Free Cash Flow | -- | -- | -- | -$377.4K | -$2.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $307.5K | $9.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | $541.7K | $518K | |
Cash Acquisitions | -- | -- | -- | -- | $35K | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -$7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$312.5K | -$10.2M | |
Depreciation & Amoritzation | -- | -- | -- | $2.2K | $10K | |
Stock-Based Compensation | -- | -- | -- | $10K | $9.3M | |
Change in Accounts Receivable | -- | -- | -- | -$507.1K | -$1.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$272.5K | -$2.7M | |
Capital Expenditures | -- | -- | -- | $105K | $70K | |
Cash Acquisitions | -- | -- | -- | -- | $35K | |
Cash From Investing | -- | -- | -- | -$105K | $1.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $899.7K | |
Long-Term Debt Repaid | -- | -- | -- | -$23.5K | -$34.4K | |
Repurchase of Common Stock | -- | -- | -- | -- | -$1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -$23.5K | $3.2M | |
Beginning Cash (CF) | -- | -- | -- | $607.9K | $40.8K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$400.9K | $2.2M | |
Ending Cash (CF) | -- | -- | -- | $206.9K | $2.3M | |
Levered Free Cash Flow | -- | -- | -- | -$377.4K | -$2.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.